WASHINGTON, Dec. 15 (Xinhua) -- Researchers at
University of Pennsylvania have discovered stem cells in the esophagus of mice
that were able to grow into tissue-like structures and when placed into
immune-deficient mice were able to form parts of an esophagus lining.
The investigators report their findings online on
Monday in the Journal of Clinical Investigation.
"The immediate implication is that we'll have a
better understanding of the role of these stem cells in normal biology, as well
as in regenerative and cancer biology," says senior author Anil Rustgi. "Down
the road, we might use these stem cells in replacement therapy for diseases like
gastroesophogeal reflux disease (GERD) and also to understand Barrett's
esophagus, a precursor to esophageal adenocarcinoma and how to reverse that
before it becomes cancer."
The researchers set out to identify and characterize
potential stem cells -- those with the ability to self renew -- in the esophagus
to understand normal biology and how injured cells may one day be repaired.
First, they grew mouse esophageal cells they
suspected were adult stem cells. Those cells formed colonies that self renewed.
These cells then grew into esophageal lining tissue in a three-dimensional
culture apparatus. "These tissue culture cells formed a mature epithelium
sitting on top of the matrix," says Rustgi.
They then tested their pieces of esophageal lining in
whole animals. When the tissue-engineered patches were transplanted under the
skin of immune-deficient mice, the cells formed epithelial structures.
Additionally, in a mouse model of injury of the esophagus in a normal mouse,
which mimics what happens during acid reflux, green-stained stem cells migrated
to the injured lining cells and co-labeled with the repaired cells, indicating
involvement of the stem cells in tissue repair and regeneration.
Eventually the researchers will develop genetically
engineered mouse models to be able to track molecular markers of esophageal stem
cells. The group has already developed a library of human esophageal cell lines
and is looking for human versions of markers already identified in mice.
"The ultimate goal is to identify esophageal stem
cells in a patient, grow the patient's own stem cells, and inject them locally
to replace diseased tissue with normal lining," says Rustgi.